Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 1283

1.

Aging in skin of color: Disruption to elastic fiber organization is detrimental to skin's biomechanical function.

Langton AK, Alessi S, Hann M, Chien AL, Kang S, Griffiths CEM, Watson REB.

J Invest Dermatol. 2018 Nov 4. pii: S0022-202X(18)32790-8. doi: 10.1016/j.jid.2018.10.026. [Epub ahead of print]

PMID:
30404021
2.

Predominance of triple wild-type and IGF2R mutations in mucosal melanomas.

Iida Y, Salomon MP, Hata K, Tran K, Ohe S, Griffiths CF, Hsu SC, Nelson N, Hoon DSB.

BMC Cancer. 2018 Oct 30;18(1):1054. doi: 10.1186/s12885-018-4977-2.

3.

A Systematic Review of the Effectiveness of Acceptance and Commitment Therapy (ACT) for Body Image Dissatisfaction and Weight Self-Stigma in Adults.

Griffiths C, Williamson H, Zucchelli F, Paraskeva N, Moss T.

J Contemp Psychother. 2018;48(4):189-204. doi: 10.1007/s10879-018-9384-0. Epub 2018 Feb 21.

4.

Two interferon gamma release assays for predicting active tuberculosis: the UK PREDICT TB prognostic test study.

Abubakar I, Lalvani A, Southern J, Sitch A, Jackson C, Onyimadu O, Lipman M, Deeks JJ, Griffiths C, Bothamley G, Kon OM, Hayward A, Lord J, Drobniewski F.

Health Technol Assess. 2018 Oct;22(56):1-96. doi: 10.3310/hta22560.

5.

Aged human skin accumulates mast cells with altered functionality which localise to macrophage and VIP+ nerve fibres.

Pilkington SM, Barron MJ, Watson REB, Griffiths CEM, Bulfone-Paus S.

Br J Dermatol. 2018 Oct 6. doi: 10.1111/bjd.17268. [Epub ahead of print]

PMID:
30291626
6.

MicroCT imaging applied to description of a new species of Pagurus Fabricius, 1775 (Crustacea: Decapoda: Anomura: Paguridae), with selection of three-dimensional type data.

Landschoff J, Komai T, du Plessis A, Gouws G, Griffiths CL.

PLoS One. 2018 Sep 26;13(9):e0203107. doi: 10.1371/journal.pone.0203107. eCollection 2018.

7.

Can big data solve a big problem? Reporting the obesity data landscape in line with the Foresight obesity system map.

Morris MA, Wilkins E, Timmins KA, Bryant M, Birkin M, Griffiths C.

Int J Obes (Lond). 2018 Sep 21. doi: 10.1038/s41366-018-0184-0. [Epub ahead of print]

8.

Low-dose interleukin-2 in patients with stable ischaemic heart disease and acute coronary syndromes (LILACS): protocol and study rationale for a randomised, double-blind, placebo-controlled, phase I/II clinical trial.

Zhao TX, Kostapanos M, Griffiths C, Arbon EL, Hubsch A, Kaloyirou F, Helmy J, Hoole SP, Rudd JHF, Wood G, Burling K, Bond S, Cheriyan J, Mallat Z.

BMJ Open. 2018 Sep 17;8(9):e022452. doi: 10.1136/bmjopen-2018-022452.

9.

Pregnancy-associated Cushing's disease? An exploratory retrospective study.

Palejwala SK, Conger AR, Eisenberg AA, Cohan P, Griffiths CF, Barkhoudarian G, Kelly DF.

Pituitary. 2018 Sep 14. doi: 10.1007/s11102-018-0910-6. [Epub ahead of print]

PMID:
30218242
10.

Prognostic value of interferon-γ release assays and tuberculin skin test in predicting the development of active tuberculosis (UK PREDICT TB): a prospective cohort study.

Abubakar I, Drobniewski F, Southern J, Sitch AJ, Jackson C, Lipman M, Deeks JJ, Griffiths C, Bothamley G, Lynn W, Burgess H, Mann B, Imran A, Sridhar S, Tsou CY, Nikolayevskyy V, Rees-Roberts M, Whitworth H, Kon OM, Haldar P, Kunst H, Anderson S, Hayward A, Watson JM, Milburn H, Lalvani A; PREDICT Study Team.

Lancet Infect Dis. 2018 Oct;18(10):1077-1087. doi: 10.1016/S1473-3099(18)30355-4. Epub 2018 Aug 30.

11.

Cost-effectiveness of a domestic violence and abuse training and support programme in primary care in the real world: updated modelling based on an MRC phase IV observational pragmatic implementation study.

Barbosa EC, Verhoef TI, Morris S, Solmi F, Johnson M, Sohal A, El-Shogri F, Dowrick S, Ronalds C, Griffiths C, Eldridge S, Lewis NV, Devine A, Spencer A, Feder G.

BMJ Open. 2018 Aug 29;8(8):e021256. doi: 10.1136/bmjopen-2017-021256.

12.

A small population, randomised, placebo-controlled trial to determine the efficacy of anakinra in the treatment of pustular psoriasis: study protocol for the APRICOT trial.

Cornelius V, Wilson R, Cro S, Barker J, Burden D, Griffiths CEM, Lachmann H, McAteer H, Reynolds N, Pink A, Warren RB, Capon F, Smith C.

Trials. 2018 Aug 29;19(1):465. doi: 10.1186/s13063-018-2841-y.

13.

Identifying demographic, social and clinical predictors of biologic therapy effectiveness in psoriasis: a multicentre longitudinal cohort study.

Warren RB, Marsden A, Tomenson B, Mason KJ, Soliman MM, Burden AD, Reynolds NJ, Stocken D, Emsley R, Griffiths CEM, Smith C; PSORT Consortium and on behalf of the BADBIR Study Group.

Br J Dermatol. 2018 Aug 28. doi: 10.1111/bjd.16776. [Epub ahead of print]

PMID:
30155885
14.

Vitamin D receptor genotype influences risk of upper respiratory infection.

Jolliffe DA, Greiller CL, Mein CA, Hoti M, Bakhsoliani E, Telcian AG, Simpson A, Barnes NC, Curtin JA, Custovic A, Johnston SL, Griffiths CJ, Walton RT, Martineau AR.

Br J Nutr. 2018 Oct;120(8):891-900. doi: 10.1017/S000711451800209X. Epub 2018 Aug 22.

PMID:
30132432
15.

Defining the therapeutic range for adalimumab and predicting response in psoriasis: a multicenter prospective observational cohort study.

Wilkinson N, Tsakok T, Dand N, Bloem K, Duckworth M, Baudry D, Pushpa-Rajah A, Griffiths CE, Reynolds N, Barker J, Warren RB, Burden AD, Rispens T, Stocken D, Smith C; BSTOP study group and PSORT consortium.

J Invest Dermatol. 2018 Aug 18. pii: S0022-202X(18)32482-5. doi: 10.1016/j.jid.2018.07.028. [Epub ahead of print]

16.

Long-Term Efficacy of Guselkumab for the Treatment of Moderate-to-Severe Psoriasis: Results from the Phase 3 VOYAGE 1 Trial Through Two Years.

Griffiths CEM, Papp KA, Kimball AB, Randazzo B, Song M, Li S, Shen YK, Blauvelt A.

J Drugs Dermatol. 2018 Aug 1;17(8):826-832.

PMID:
30124721
17.

Generating EQ-5D-3L Utility Scores from the Dermatology Life Quality Index: A Mapping Study in Patients with Psoriasis.

Davison NJ, Thompson AJ, Turner AJ, Longworth L, McElhone K, Griffiths CEM, Payne K; BADBIR Study Group.

Value Health. 2018 Aug;21(8):1010-1018. doi: 10.1016/j.jval.2017.10.024. Epub 2017 Dec 26.

PMID:
30098665
18.

Improving the healthcare response to domestic violence and abuse in primary care: protocol for a mixed method evaluation of the implementation of a complex intervention.

Sohal AH, Feder G, Barbosa E, Beresford L, Dowrick A, El-Shogri F, Howell A, Lewis N, Johnson M, Nightingale C, Boomla K, Morris S, Eldridge S, Griffiths C.

BMC Public Health. 2018 Aug 3;18(1):971. doi: 10.1186/s12889-018-5865-z.

19.

Scaling marine fish movement behavior from individuals to populations.

Griffiths CA, Patterson TA, Blanchard JL, Righton DA, Wright SR, Pitchford JW, Blackwell PG.

Ecol Evol. 2018 Jun 25;8(14):7031-7043. doi: 10.1002/ece3.4223. eCollection 2018 Jul.

20.

Infliximab is associated with an increased risk of serious infection in patients with psoriasis in the U.K. and Republic of Ireland: results from the British Association of Dermatologists Biologic Interventions Register (BADBIR).

Yiu ZZN, Ashcroft DM, Evans I, McElhone K, Lunt M, Smith CH, Walton S, Murphy R, Reynolds NJ, Ormerod AD, Griffiths CEM, Warren RB; BADBIR Study Group.

Br J Dermatol. 2018 Aug 2. doi: 10.1111/bjd.17036. [Epub ahead of print]

PMID:
30070708

Supplemental Content

Loading ...
Support Center